| Year |
Citation |
Score |
| 2013 |
VanAlstine MA, Wentland MP, Alvarez J, Cao Q, Cohen DJ, Knapp BI, Bidlack JM. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 9: Synthesis, characterization and molecular modeling of pyridinyl isosteres of N-BPE-8-CAC (1), a high affinity ligand for opioid receptors. Bioorganic & Medicinal Chemistry Letters. 23: 2128-33. PMID 23434225 DOI: 10.1016/J.Bmcl.2013.01.117 |
0.703 |
|
| 2012 |
Yang J, VanAlstine MA, Phillips JG, Wentland MP, Hough LB. Cytochrome P450 2C24: Expression, Tissue Distribution, High-Throughput Assay, and Pharmacological Inhibition. Acta Pharmaceutica Sinica. B. 2: 137-145. PMID 25068100 DOI: 10.1016/J.Apsb.2012.02.003 |
0.543 |
|
| 2012 |
Wentland MP, Jo S, Gargano JM, VanAlstine MA, Cohen DJ, Bidlack JM. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 8. High affinity ligands for opioid receptors in the picomolar Ki range: oxygenated N-(2-[1,1'-biphenyl]-4-ylethyl) analogues of 8-CAC. Bioorganic & Medicinal Chemistry Letters. 22: 7340-4. PMID 23142613 DOI: 10.1016/J.Bmcl.2012.10.081 |
0.698 |
|
| 2011 |
Hough LB, Nalwalk JW, Yang J, Conroy JL, VanAlstine MA, Yang W, Gargano J, Shan Z, Zhang SZ, Wentland MP, Phillips JG, Knapp BI, Bidlack JM, Zuiderveld OP, Leurs R, et al. Brain P450 epoxygenase activity is required for the antinociceptive effects of improgan, a nonopioid analgesic. Pain. 152: 878-87. PMID 21316152 DOI: 10.1016/J.Pain.2011.01.001 |
0.624 |
|
| 2010 |
Conroy JL, Fang C, Gu J, Zeitlin SO, Yang W, Yang J, VanAlstine MA, Nalwalk JW, Albrecht PJ, Mazurkiewicz JE, Snyder-Keller A, Shan Z, Zhang SZ, Wentland MP, Behr M, et al. Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signaling. Nature Neuroscience. 13: 284-6. PMID 20139973 DOI: 10.1038/Nn.2497 |
0.614 |
|
| 2009 |
Wentland MP, Lou R, Lu Q, Bu Y, Denhardt C, Jin J, Ganorkar R, VanAlstine MA, Guo C, Cohen DJ, Bidlack JM. Syntheses of novel high affinity ligands for opioid receptors. Bioorganic & Medicinal Chemistry Letters. 19: 2289-94. PMID 19282177 DOI: 10.1016/J.Bmcl.2009.02.078 |
0.692 |
|
| 2009 |
Wentland MP, Lou R, Lu Q, Bu Y, VanAlstine MA, Cohen DJ, Bidlack JM. Syntheses and opioid receptor binding properties of carboxamido-substituted opioids. Bioorganic & Medicinal Chemistry Letters. 19: 203-8. PMID 19027293 DOI: 10.1016/J.Bmcl.2008.10.134 |
0.695 |
|
| 2007 |
VanAlstine MA, Wentland MP, Cohen DJ, Bidlack JM. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 5. Opioid receptor binding properties of N-((4′-phenyl)-phenethyl) analogues of 8-CAC Bioorganic and Medicinal Chemistry Letters. 17: 6516-6520. PMID 17935988 DOI: 10.1016/J.Bmcl.2007.09.082 |
0.721 |
|
| 2006 |
Wentland MP, VanAlstine M, Kucejko R, Lou R, Cohen DJ, Parkhill AL, Bidlack JM. Redefining the structure-activity relationships of 2,6-methano-3- benzazocines. 4. Opioid receptor binding properties of 8-[n-(4′-phenyl)- phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine Journal of Medicinal Chemistry. 49: 5635-5639. PMID 16942039 DOI: 10.1021/Jm060278N |
0.728 |
|
| 2003 |
Lou R, VanAlstine M, Sun X, Wentland MP. Preparation of N-hydroxysuccinimido esters via palladium-catalyzed carbonylation of aryl triflates and halides Tetrahedron Letters. 44: 2477-2480. DOI: 10.1016/S0040-4039(03)00337-X |
0.612 |
|
| 2003 |
Lou R, VanAlstine M, Sun X, Wentland MP. Preparation of N-Hydroxysuccinimido esters via Palladium-Catalyzed Carbonylation of Aryl Triflates and Halides. Cheminform. 34. DOI: 10.1002/chin.200326070 |
0.497 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2011 |
VanAlstine MA, Hough LB. Effects of acetylenic epoxygenase inhibitors on recombinant cytochrome p450s. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 39: 1221-6. PMID 21460231 DOI: 10.1124/Dmd.110.037424 |
0.169 |
|
| Hide low-probability matches. |